Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$27,000.00

Exploring Alternative Pathways Driving Inflammation and Gene Expression in Airway Epithelial Cells

FY 2024-25

Summary
Asthma is a chronic inflammatory disease of the airways that affects millions of people annually. While inhaled glucocorticoids (GCs) effectively manage mild-to-moderate asthma, severe asthma is often unresponsive to treatment – representing a significant unmet clinical need. Patients with severe asthma are typically given higher doses of GCs, which increases the risk of side effects despite failure to control symptoms. A key obstacle to addressing this issue is an incomplete understanding of molecular mechanisms underlying airway inflammation. Central to airway inflammation is nuclear factor-kB (NF-kB), a transcription factor which is essential to drive the expression of many, potentially most, inflammatory genes. NF-kB is activated by a cascade of intracellular signalling molecules, known as the NF-kB pathway. While the core NF-kB cascade is well-characterized, there are many components which remain poorly studied. These components may play distinct functional roles, which may shift the understanding of how NF-kB signalling operates. This research aims to address these gaps by using small-molecule inhibitors, gene silencing, and gene deletion to target various NF-kB pathway components. Additionally, next-generation sequencing approaches will be used to identify NF-kB-dependent genes, linking the distinct roles of pathway components to their transcriptional outcomes. Ultimately, an improved understanding of NF-kB signalling may yield additional targets for therapeutic intervention in asthma and other inflammatory conditions.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
530123
Name
Gao Alex
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring Alternative Pathways Driving Inflammation and Gene Expression in Airway Epithelial Cells
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Airway Epithelial Cells; Cytokines; Gene Regulation; Immunology; Inflammation; Kinases; Molecular Biology; Nuclear-Factor Kappa-B (Nf-Kb); Rna Sequencing; Signal Transduction
Abstract
Asthma is a chronic inflammatory disease of the airways that affects millions of people annually. While inhaled glucocorticoids (GCs) effectively manage mild-to-moderate asthma, severe asthma is often unresponsive to treatment – representing a significant unmet clinical need. Patients with severe asthma are typically given higher doses of GCs, which increases the risk of side effects despite failure to control symptoms. A key obstacle to addressing this issue is an incomplete understanding of molecular mechanisms underlying airway inflammation. Central to airway inflammation is nuclear factor-kB (NF-kB), a transcription factor which is essential to drive the expression of many, potentially most, inflammatory genes. NF-kB is activated by a cascade of intracellular signalling molecules, known as the NF-kB pathway. While the core NF-kB cascade is well-characterized, there are many components which remain poorly studied. These components may play distinct functional roles, which may shift the understanding of how NF-kB signalling operates. This research aims to address these gaps by using small-molecule inhibitors, gene silencing, and gene deletion to target various NF-kB pathway components. Additionally, next-generation sequencing approaches will be used to identify NF-kB-dependent genes, linking the distinct roles of pathway components to their transcriptional outcomes. Ultimately, an improved understanding of NF-kB signalling may yield additional targets for therapeutic intervention in asthma and other inflammatory conditions.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gao, Alex
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~